Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Total 13F shares
-
33,709,299
-
Share change
-
+5,045,361
-
Total reported value
-
$7,548,281,316
-
Put/Call ratio
-
146%
-
Price per share
-
$223.88
-
Number of holders
-
275
-
Value change
-
+$1,380,454,495
-
Number of buys
-
159
-
Number of sells
-
108
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q2 2021
As of 30 Jun 2021 BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) had 275 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,709,299 shares of stock of the company.
Largest 10 holders included BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, Capital World Investors, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Fosun International Ltd, BlackRock Inc., COATUE MANAGEMENT LLC, Artisan Partners Limited Partnership, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This table shows 275 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.